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Abstract 
A skin-mimicking artificial membrane consisting of a silicone membrane as a model stratum 
corneum and laminated dialysis membranes as a model of viable skin was prepared to imitate the 
layered structure of skin.    The permeability of flurbiprofen (FP) through the laminated 
membranes agreed with that calculated, suggesting that the interfacial resistance between each 
membrane was negligible.   When the FP concentration in the laminated membranes was 
determined by microdialysis, the observed concentration was similar to that calculated according to 
Fick’s law of diffusion.   When bovine serum albumin (BSA) solution was placed between the 
dialysis membranes to mimic the protein leaching in skin, the FP permeation profiles through the 
membranes showed a long lag-time without dependence on the depth of the region of the inserted 
BSA from the surface.  However, the FP concentration-time profiles in a region between the 
membranes showed dependence on the region of the inserted BSA.   Since the FP concentration in 
the region and the permeation rates at steady-state were similar to those without BSA solution, BSA 
could act as a capacity factor to the delayed reaching to a steady-state.   The skin mimicking 
laminated membranes will be useful to evaluate drug permeation quantitatively and to imitate some 
events which can happen in inflamed tissues in skin without requiring animals.  
Key words: skin absorption, microdialysis, artificial membrane, zero net flux, protein binding  
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Introduction 
Topical formulations can be categorized into two types according to their target site of action.   
One involves the systemic action of drugs which are absorbed from the cutaneous microvessels 
while the other exhibits local effects in the skin and subcutaneous tissues (Russell and Guy, 2009).   
Since the drug disposition in the skin is important for both types of formulations, evaluation of the 
drug concentration profiles in skin is very helpful for formulation design (Touitou et al., 1998).   In 
vitro skin permeation experiments using excised skin are the most popular experimental methods to 
study skin absorption of drugs.   Since only a few pieces of excised skin can be obtained from one 
animal, the in vitro experimental systems are useful to reduce the use of experimental animals.   
However, the in vitro experimental systems are not suitable for evaluating the drug concentration 
profiles in skin because of the lack of local blood flow and physiological response (Roberts and 
Cross, 1999).   Changes in blood flow and inflammation in the local tissue can affect the drug 
concentration in skin (Ortiz et al., 2008; Clough et al., 2002).   Although such changes occur in in 
vivo systems, the in vivo experimental systems have a number  of problems, such as the detection 
limit, reproducibility and number of animal used (Morimoto et al., 2000; Shukla et al., 2009; Ortiz et 
al., 2009).   Alternatives to animal testing and experimentation are valuable not only to reduce the 
use of experimental animals but also to allow the control of experimental conditions.   Therefore, a 
new skin-mimicking in vitro experimental system as an alternative experimental technique, which 
can artificially create local inflammation, will be useful for basic studies of the skin absorption of 
drugs. 
     Skin consists of an epidermis and dermis, and the outer layer of the epidermis is the stratum 
corneum.   The stratum corneum is composed of dead keratinocyte layers and acts as a permeation 
barrier to foreign material.   Since the corneocytes are surrounded by intercellular lipids, the 
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stratum corneum is a lipophilic membrane.   Different types of artificial membrane have been 
evaluated as a model of the stratum corneum to predict the steady-state permeation rate of drugs 
through skin (de Jager et al., 2005; Ottaviani et al., 2006).   On the other hand, the viable 
epidermis and dermis have a high water content like a hydro gel and these may not work as diffusion 
barriers in most cases.   However, since the physiological changes occur in the viable skin, the 
condition of the layers can directly affect the concentration profiles of drugs in skin (Roberts and 
Cross, 1999; Ortiz et al., 2008).   Therefore, the new skin-mimicking membrane system should be 
a laminated structure and should be able to reproduce physiological changes in skin. 
     In this study, a silicone membrane was used as a model stratum corneum and laminated 
dialysis membranes were placed under the silicone membrane as a model of viable skin (Wasdo et 
al., 2009).   A microdialysis probe was inserted between the dialysis membranes to determine the 
drug concentration in the laminated membranes (Cevc and Vierl, 2007) and flurbiprofen (FP) was 
used as a model drug.   Since FP is applied to the skin surface as topical formulations to treat 
inflammation in local tissues and is highly protein-bound, the concentration profiles of FP in skin 
should be affected by inflammation and protein leaching in the skin (Evard et al., 1996; Sugibayashi 
et al., 1999).   In the new experimental system, bovine serum albumin (BSA) solution was placed 
between the dialysis membranes to mimic the protein leaching in skin. 
 
Materials and Methods 
Materials 
FP and BSA (Fraction V) were purchased from Sigma (St. Louis, MO).   Dialysis fiber 
(OP-100-10) was purchased from Eicom (Kyoto, Japan).   Silicone membranes (50 μm 
thickness) and dialysis membranes (SpectraPor 7, MWCO=1000, 50 μm thickness) were 
purchased from AS ONE (Osaka, Japan) and Funakoshi (Tokyo, Japan), respectively.   All other 
5 
 
chemicals were of reagent grade. 
Permeation experiments 
The single membrane or laminated membranes were mounted in a 2-chamber glass diffusion cell 
(effective diffusion area = 0.79 cm2, Fig. 1).   The whole cell set was kept at 37oC and FP solution 
(50 μg/mL for dialysis membranes or 500 μg/mL for silicone membranes, 2.8 mL) in an isotonic 
phosphate buffer (pH 7.0, PBS) and the buffer as a receptor medium were applied to each chamber.   
Samples of medium (200 – 2000 μL) in the receptor chamber were removed to determine the 
concentration of FP at predetermined times and fresh buffer was added to keep the volume constant.   
The sampling volume was chosen to keep the FP concentration in the receptor chamber low enough 
for sink conditions.   The samples were mixed with the same volume of p-hydroxybenzoic acid 
iso-propyl ester (internal standard) solution in methanol (2.5 μg/mL) then the supernatant (20 μL) 
was subjected to HPLC (Yanagimoto et al., 1998).   The HPLC system consisted of a pump 
(LC-10AT, Shimadzu, Kyoto, Japan), an injector (7125, Rheodyne, CA), a stainless-steel column (4 
x 250 mm) packed with LiChrospher 100 RP-18(e) (5 μm, Merck, Darmstadt, Germany), a UV 
detector (SPD-10A, Shimadzu) and an integrator (C-R5A, Shimadzu).   The mobile phase 
consisted of 3 : 2 (v : v) acetonitrile : 0.1% phosphoric acid solution, and the flow rate was 1.0 
mL/min.   The detector was operated at 245 nm. 
Fig. 1 
     The permeability coefficient (P) of FP through the membranes was calculated using the 
following equation. 
 
ΔC
FP =   (1) 
where F is the steady-state permeation rate of FP per unit area and ΔC is the concentration 
difference of FP between the donor and receptor phases.   For the laminated membranes, the 
calculated P (Pcal) was obtained from the P of each single membrane using the following equations. 
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where Pi is P through membrane i.   The obtained Pcal was compared with the corresponding P of 
the laminated membranes. 
Microdialysis for the laminated membranes 
The microdialysis probe was placed between the dialysis membranes as shown in Fig. 2a or b.   
The time schedule of microdialysis is shown in Table 1a or b and the flow rate of the dialysate was 1 
μL/min.   Application of FP to the laminated membrane surface was performed in the same way 
as in the permeation experiments.  The FP concentration in each region was determined by the zero 
net flux method (ZNF) (Whitehead et al., 2001).   Briefly for Fig. 2a, using the concentration in the 
outflow at step 1 and step 3 in Table 1a, the concentration giving zero flux was calculated as the 
x-intercept of the plot of the concentration in the inflow versus the concentration difference between 
the inflow and outflow.   At step 6 in Table 1a, the accuracy of the expected concentration was 
checked by verification of the zero net flux.   The confidence of ZNF in the in vitro skin 
permeation experiments was given in our previous report (Seki et al., 2004). 
Fig. 2 and Table 1 
     The concentration in the region can also be calculated from Fick’s law of diffusion using the 
following equation. 
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(3) 
where C1-2 is the steady-state concentration in the region between the donor-side membrane 
(membrane 1) and the receptor-side membrane (membrane 2), Cr is the concentration in the receptor 
phase, and P1 and P2 are the permeability coefficients of membrane 1 and 2, respectively.   In the 
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case of two dialysis membranes (Fig. 2a), the FP concentration in the region can be calculated by = 
0.5×ΔC + Cr because the concentration is the mean value of the concentration in the donor and 
receptor phases.   In the case of skin-mimicking membranes (Fig. 2b), firstly, the FP concentration 
in  region A in Fig. 2b was calculated using equation (3) and then the concentration in the objective 
region (region C in Fig. 2b, Cc) was obtained as the mean of the concentrations in  regions A and Cr.   
If the experimental conditions were regarded as sink conditions, Cr is negligible in these calculations.   
These calculated concentration values were compared with the corresponding concentration values 
using ZNF. 
Mimicking protein leaching into the membranes 
In order to mimic protein leaching in skin as a pathophysiological effect of inflammation, 20 μL of 
BSA solution (1%) was placed in region B or D in Fig. 2b.   Application of FP on the laminated 
membrane surface was carried out in the same way as in the permeation experiments and FP free 
dailysate was allowed to flow continuously at 1 μL/min.   The concentration in the region C (Cc) 
was obtained using following equation (Kehr, 1993). 
 




−
−
=
Q
CL
o
m
CC
e
c
1
   (4) 
where Co is the concentration in the outflow, CLm is the permeation clearance of the dialysis probe 
and Q is the flow rate of the dialysate (1 μL/min).   The value of CLm was obtained from the 
relationship between Q (1 - 20 μL/min) and Co with an equilibrium FP solution (1 μg/mL) in the 
cell system; it was 0.330±0.022 μL/min for the probe used in this study. 
 
Results 
Permeation of FP through the laminated membranes 
Fig. 3a shows the permeation profiles of FP through dialysis membranes.   The permeation rates 
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were reduced depending on the number of layers.   The observed P values of the laminated 
membranes were similar to the Pcal values calculated from the P for the single membrane, suggesting 
that interfacial resistance between the membranes was negligible (Table 2).  The permeation of FP 
through the single silicone membrane was about 20 times lower than that through the single dialysis 
membrane (Fig. 3b).   The skin-mimicking membrane consisted of a single silicone membrane and 
four dialysis membranes showed a long lag-time although the permeation rate of FP was not very 
different from that through the single silicone membrane.   The P value through the 
skin-mimicking membrane was similar to the Pcal value calculated from the observed P of the single 
silicone membrane and the laminated membranes of four dialysis membranes, and the value was 
about 80% of that of the single silicone membrane.   Although the contribution of the viable 
epidermis and dermis to the permeation resistance of a full thickness skin was different for each drug 
and the permeability ratio of the stratum corneum to the viable epidermis and dermis depended on 
the physicochemical properties of the drugs, most drugs show a lower permeability for the stratum 
corneum than viable skin and the stratum corneum is the major rate-limiting barrier to the skin 
permeation of drugs (Roberts and Cross, 1999).   Accordingly, the skin-mimicking membrane 
presented here is similar to skin, although the absolute permeability of FP was not compared with 
that through human skin.    
Fig. 3 and Table 2 
Determination of FP concentration between two dialysis membranes by ZNF 
In order to verify the appropriateness of ZNF, the FP concentration between two dialysis membranes 
with a steady-state permeation of FP was determined (Fig. 2a).   Fig. 4a shows a comparison of the 
permeation profiles between two simple dialysis membranes and two dialysis membranes with a 
dialysis probe at 1 μL/min microdialysis with PBS.  The FP permeation through the membrane 
with dialysis was slightly lower than that without dialysis but there was no significant difference 
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between the permeation rates.   The reduction in FP permeated is related to the 
permeation-resistance as the presence of the probe and removing FP into the dialysate.   The 
amount of FP withdrawn into the dialysate was about 1 μg over 120 min and that was reasonable to 
explain the reduction.   Anyway, the effect of dialysis on the permeation of FP was very low, and 
the FP concentration between two dialysis membranes can be calculated using equation (3) and can 
be determined by ZNF (Seki et al., 2004).   After the permeation experiment for 120 min, 40 μ
g/mL  FP solution was perfused into the dialysis probe to obtain a negative  net flux (steps 2 and 3 
in Table 1a).   The FP concentration between two dialysis membranes as the concentration giving 
zero flux into the dialysate was calculated as the x-intercept of the plot of the concentration in the 
inflow (0 and 40 μg/mL) versus the concentration difference between the inflow and outflow (9.0 
± 0.4 and -6.0 ± 0.4 μg/mL) (Fig. 4b).   The obtained value was 23.9 ± 0.9 μg/mL and 
this was similar to that calculated by equation (3) (25μg/mL under the assumption of sink 
conditions).   The same FP concentration solution was prepared and the solution was perfused into 
the probe at steps 5 and 6 in Table 1a to evaluate the validity of this methodology.   The observed 
FP concentration in the outflow at step 6 was 24.5 ± 0.4 μg/mL and the net flux was nearly zero, 
confirming  the validity of ZNF. 
Fig. 4 
     The FP concentration in region C shown in Fig. 2b for the skin-mimicking laminated 
membranes was also determined using ZNF.   The time schedule is given in Table 1b. The 
cumulative amount of FP permeated through the membranes was determined for all the steps (step 0 
– step 8) and is shown in Fig. 5 (-■-).   The steady-state permeation rate through the membrane 
system dialyzed was also similar to that through the skin-mimicking membrane without dialysis (-□
- in Fig. 3b), suggesting that the dialysis in the membrane system is of no consequence for such FP 
permeation.   At  steps 2 and 5, 20μg/mL and 50 μg/mL  FP solution were perfused  to 
10 
 
obtain positive and negative values of net flux, respectively.   The FP concentration in the outflow 
at  steps 2 and 5 was 24.7 ± 0.5 μg/mL and 48.0 ± 0.6 μg/mL, respectively (Fig. 6a and 
Table 1b) and the net flux values were plotted to obtain the FP concentration giving zero net flux 
(Fig. 6b).   At  step 8, 41.3 ± 1.3 μg/mL of FP solution as the suggested concentration in Fig. 
6b was perfused to validate the determination.   The observed FP concentration in the outflow was 
41.2 ± 1.8 μg/mL, also confirming the validity of this methodology.   The FP concentration in 
region C can be calculated using equation (3) twice.   Under the assumption of  sink conditions, 
the FP concentration in region A was calculated as 67.5 μg/mL from the values of the permeability 
of FP through the single silicone membrane and four dialysis membranes (Table 2) first and then the 
FP concentration in region C was obtained as half of this value which was  33.8μg/mL.   
Considering the total concentration difference of 500μg/mL, the calculated value was reasonably 
close  to the observed value using ZNF. 
Figs. 5 and 6 
Effect of BSA in the skin mimicking membrane on the permeation of FP 
In inflamed tissues, vascular permeability increases and some types of proteins leach out of plasma 
into the extracellular space (Ortiz et al., 2008).   In order to imitate such situations, BSA solution 
was placed in region B or D in the skin-mimicking laminated membranes (Fig. 2b) and the effects on 
the permeation of FP were evaluated.  The FP concentration in region C was determined using 
equation (4), not by ZNF, to obtain the concentration-time profile before steady-state.  The FP 
permeation profiles through the membranes with BSA solution showed a long lag-time but the 
steady- state permeation rates were not very different from that without BSA solution (-○- and –△- 
in Fig. 5).   No significant difference in the profiles was found for the region of BSA solution 
inserted.  The BSA solution could work as a capacity factor to delay reaching steady- state.   Fig. 
7 shows the FP concentration-time profiles in region C.   In the case of BSA placed in region B, the 
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FP concentration in region C increased gradually over 360 min and the appearance of FP in the 
receptor medium was proportional to the concentration in region C.   Although transfer of FP from 
the donor to region C was interfered with BSA placed in region B, FP in region C could simply 
diffuse to the receptor according to Fick’s law.   On the other hand, the FP concentration in region 
C for the membrane in which BSA solution was placed in region D achieved a steady level in 120 
min, although the time to achieve steady-state permeation through the laminated membranes was 
about 360 min.   This result suggests that the amount of FP binding to BSA placed in region D 
increased for almost 360 min and the increase in binding suppressed the appearance of FP in the 
receptor phase, even if the FP concentration in region C was high enough.   In  both cases, the FP 
concentration in region C could be 35 – 40 μg/mL at  steady- state and the values were close to 
those determined by ZNF (41.3 μg/mL) and calculated using equation (3) (33.8μg/mL) for the 
membranes without BSA solution.   This result suggests that BSA can work as a capacity factor to 
keep FP in the region but the FP concentration in the other region is unaffected by BSA.   This 
means that the concentration-distance profiles of free (unbound) FP in the laminated membranes are 
not influenced by the presence of BSA at steady-state for permeation. 
Fig. 7 
 
Discussion 
Although in vitro experimental systems using excised skins from experimental animals are generally 
used for studies on skin absorption of drugs, they are not suitable to evaluate the drug concentration 
profiles in skin because of the lack of local blood flow and physiological response.   Therefore, a 
new skin-mimicking in vitro experimental system consisting of artificial membranes will be useful 
for basic studies on the skin absorption of drugs.   In this study, a silicone membrane was used as a 
model stratum corneum and laminated dialysis membranes were placed under the silicone membrane 
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as a model of viable skin to imitate the layered structure of skin.  The P of the laminated 
membranes agreed with that calculated from the P of the component membranes (Table 2), 
suggesting that the interfacial resistance between each membrane was negligible.  The FP 
concentration in a region between the membranes was determined using ZNF to evaluate the 
concentration-distance profiles through the laminated membranes.   The observed concentration 
was similar to that calculated using equation (3).   These results suggest that the skin-mimicking 
laminated membranes represent a suitable model, giving results that agreed with Fick’s law of 
diffusion. 
     In order to confirm the value of this model, as an example, the effects of BSA placed between 
the membranes on the permeation profiles of FP through the membranes were examined.   
Although protein leaching into the extracellular space of inflamed skin tissues can affect the 
disposition of drug in the skin, especially for highly protein-bound drugs, examination of such a 
complex process consisting of diffusion and binding may be difficult in in vitro experiments using 
excised skin and in in vivo absorption studies (Morimoto et al., 2000).   In this study, BSA solution 
was placed in two different regions (region B and D in Fig. 2b) and the effects on the permeation 
profiles and the concentration between the membranes (region C in Fig. 2b) were examined.   
Although the FP permeation profiles through the membranes with BSA solution showed a long lag- 
time, the steady-state permeation rates were not very different from that without BSA solution and 
the profiles were independent of where the BSA was located (-○- and –△- in Fig. 5).   On the 
other hand, the FP concentration profiles in region C were different with regard to the location of 
BSA  before steady-state, suggesting that BSA solution worked as a capacity factor to delay 
reaching steady-state.   The concentration-distance profiles of free FP in the laminated membranes 
were not influenced by the presence of BSA at steady-state. 
     Since the dialysis membranes used as a model viable skin in the skin-mimicking laminated 
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membranes had a low MW cut-off (MWCO=1000), BSA placed in one region could not diffuse to 
the other region in the system.   Although this is good for obtaining clear results, proteins leaching 
into the extracellular space in inflamed tissues can diffuse according to the concentration gradient in 
actual situations.   The use of dialysis membranes having a higher MW cut-off than that of binding 
proteins as model viable skin will give valuable information about the contribution of proteins to 
drug transfer.   The effects will depend on the direction of the concentration gradient of the protein 
itself.   Using skin-mimicking laminated membranes, any direction of protein concentration 
gradient can be recreated in the laminated membranes.   Since the viable epidermis and dermis 
have different cellular densities and components, the diffusion of proteins can differ depending on 
their extracellular aqueous space.   Recently, a tight junction structure was found in the viable 
epidermis (Wakamatsu et al., 2007; Proksch et al., 2008) and this complicated our understanding of 
the viable epidermis with regard to drug diffusion.   The tight junctions may work as specific 
molecular sieves for penetrants.   Lamination of different types of dialysis membranes can be 
helpful to imitate such complicated structures of viable skin in a simple way. 
     In this study, the microdialysis probe was placed in the laminated membranes to determine the 
concentration in the local region.   In another way, microdialysis probes can be used as model 
vessels to imitate blood flow in skin.   Although the blood flow rate in skin affects the uptake of 
drugs from the dermis into the bloodstream, the flow rate is difficult to control in in vivo studies.   
The contributions of the interaction of drugs with components in the blood, e. g. plasma protein 
binding, to the drug uptake are also difficult to evaluate quantitatively.   If microdialysis probes are 
used as model vessels, the flow rate can be controlled simply and the composition of the model 
blood can be chosen freely (Seki et al., 2004).   The microdialysis probe used was impermeable to 
BSA and that can generally be used to determine the concentration of unbound drugs.   Another 
type of microdialysis probe showing permeability for BSA is commercially available.   Such a 
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microdialysis probe can be used to determine the total concentration of drugs in a region of BSA 
placed in the skin-mimicking membranes.   In addition, the probe can be used to imitate vessels 
exhibiting high permeability in inflamed tissues.   If such a probe is used as a model vessel, 
proteins in the model blood and the medium itself will leach out into the extra vascular space in the 
skin-mimicking membranes.   Such progressive edema can affect the permeation of drugs through 
the membranes. 
     In conclusion, skin-mimicking laminated membranes as an alternative to animal 
experimentation were prepared and examined as a tool for studying transdermal drug absorption.   
The laminated membranes are useful for obtaining quantitative results for FP permeation through 
membranes.   In the addition, such membranes can be used to imitate some events which may 
occur in inflamed tissues in skin.   Studies using such membranes are valuable for understanding 
the details of the skin absorption of drugs and to reduce the use of experimental animals. 
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Table 1   Time schedules for microdialysis 
(a)   Schedule for Fig. 2a set up 
  Time Flow inflow  outflow  out-in  
  (min) (μL/min) (μg/mL) (μg/mL) (μg/mL) 
step 0 0-20 1 0 - - 
step 1 20-120 1 0 8.96±0.39 8.96±0.39 
step 2 120-140 1 40 - - 
step 3 140-170 1 40 34.0±0.4 -6.0±0.4 
step 4 170-200 - - - - 
step 5 200-220 1 23.9±0.9 - - 
step 6 220-250 1 23.9±0.9 24.5±0.4 0.5±0.6 
Data are expressed as mean ±SD (n=3). 
 
(b)   Schedule for Fig. 2b set up 
  Time Flow inflow  outflow  out-in  
  (min) (μL/min) (μg/mL) (μg/mL) (μg/mL) 
step 0 0-30 - - - - 
step 1 30-60 1 20 - - 
step 2 60-90 1 20 24.7±0.5 4.7±0.5 
step 3 90-120 - - - - 
step 4 120-150 1 50 - - 
step 5 150-180 1 50 48.0±0.6 -2.0±0.6  
step 6 180-210 - - - - 
step 7 210-240 1 41.3±1.3 - - 
step 8 240-270 1 41.3±1.3 41.2±1.8 -0.1±0.6  
Data are expressed as mean ±SD (n=3). 
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Table 2   Observed and calculated permeability coefficients of FP through single or laminated 
membranes 
 
Observed permeability (cm/min)  Calculated permeability (cm/min) 
 Single dialysis membrane   3.76×10-3±0.11×10-3    -  
   Two dialysis membranes   1.90×10-3±0.17×10-3    1.88×10-3  a  
 Three dialysis membranes   1.39×10-3±0.03×10-3    1.25×10-3  a  
  Four dialysis membranes   1.14×10-3±0.10×10-3    0.94×10-3  a  
  Five dialysis membranes   0.87×10-3±0.05×10-3    0.75×10-3  a  
  Single silicone membrane   1.78×10-4±0.08×10-4    -  
  Silicone membrane with four  
  dialysis membranes  
 1.45×10-4±0.16×10-4    1.54×10-4  b  
a: Calculated using the observed value of the single dialysis membrane. 
b: Calculated using the observed value of the single silicone membrane and four dialysis 
membranes. 
Data are expressed as mean ±SD (n=3). 
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Fig. 3 
 
 
   (a)         (b) 
 
 
23 
 
 
Fig. 4 
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Figure Legends 
 
Fig. 1   Permeation experiments set up for single or laminated membranes 
 
Fig. 2   Permeation experiments set up with microdialysis 
(a) Two dialysis membranes 
(b) Single silicone membrane and four dialysis membranes (skin-mimicking membrane) 
 
Fig. 3   Permeation profiles of FP through single or laminated membranes 
(a) ■ , single dialysis membrane; △ , two dialysis membranes; ▲ , three dialysis 
membranes; ◇, four dialysis membranes; ◆, five dialysis membranes. 
(b) ○ , single silicone membrane; □ , single silicone membrane and four dialysis 
membranes = skin-mimicking membrane. 
Data are expressed as mean ±SD (n=3). 
 
Fig. 4   Application of microdialysis for permeation of FP through two dialysis membranes 
(a) Effect of microdialysis on the permeation profiles of FP: ◇, FP permeation without 
microdialysis; ◆, FP permeation with microdialysis (FP free solution, 1 μL/min). 
(b) Net flux plots of FP to determine the FP concentration giving zero net flux: the 
x-intercept giving zero net flux means the expected FP concentration in the region the probe 
is located (region C in Fig. 2b). 
Data are expressed as mean ±SD (n=3). 
 
Fig. 5   Effects of BSA solution placed between dialysis membranes in the skin-mimicking 
membrane on the permeation profiles of FP with microdialysis 
■, without BSA solution; ○, BSA solution (1%, 20 μL) in region B in Fig. 2b; △, BSA 
solution (1%, 20 μL) in region D in Fig. 2b. 
Data are expressed as mean ±SD (n=3). 
 
Fig. 6   Microdialysis evaluation for FP permeation through the skin-mimicking membrane 
(a) FP concentration in the outflow (Table 1b). 
(b) Net flux plots of FP to obtain the FP concentration giving zero net flux: the x-intercept 
giving zero net flux means the expected FP concentration in the region the probe was placed 
(region C in Fig. 2b). 
Data are expressed as mean ±SD (n=3). 
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Fig. 7   FP concentration-time profiles in region C in Fig 2b for FP permeation through the skin- 
mimicking membrane with BSA solution 
○, BSA solution (1%, 20 μL) in region B in Fig. 2b; △, BSA solution (1%, 20 μL) in 
region D in Fig. 2b.   The FP concentration was calculated using equation (4). 
Data are expressed as mean ±SD (n=3). 
 
 
 
